CGEN
CGEN
NASDAQ · Biotechnology

Compugen Ltd

$2.12
+0.03 (+1.44%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +2,091.5% upside
Low Target $33.82
Average Target $46.46
High Target $60.35
Current Price $2.12
Current
$2.12
Target
$46.46
$33.82 $46.46 avg $60.35
Scenario Analysis
Bear Case
$33.82
1,495.3%
Low target
Base Case
$46.46
+2,091.5%
Avg target
Bull Case
$60.35
+2,746.7%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$3.24
-34.5% from high
52-Week Low
$1.43
+48.3% from low
Target vs 52W High
$46.46
+1,336.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%